Benjamin Weber

2.0k total citations · 1 hit paper
34 papers, 870 citations indexed

About

Benjamin Weber is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Benjamin Weber has authored 34 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 6 papers in Epidemiology. Recurrent topics in Benjamin Weber's work include Inhalation and Respiratory Drug Delivery (11 papers), Asthma and respiratory diseases (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Benjamin Weber is often cited by papers focused on Inhalation and Respiratory Drug Delivery (11 papers), Asthma and respiratory diseases (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Benjamin Weber collaborates with scholars based in United States, Germany and France. Benjamin Weber's co-authors include Günther Hochhaus, Jens Markus Borghardt, Alexander Staab, Charlotte Kloft, Muriel Barberi‐Heyob, Jean‐Louis Merlin, Elodie L. Plan, Juan José Pérez Ruixo, Thi Huyen Tram Nguyen and Immanuel Freedman and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Benjamin Weber

34 papers receiving 850 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

2016 292 citations Thi Huyen Tram Nguyen, Samer Mouksassi et al. CPT Pharmacometrics & Systems Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Weber United States	14	290	220	188	146	103	34	870
Donald Heald United States	20	127 0.4×	351 1.6×	252 1.3×	97 0.7×	81 0.8×	36	917
Arno Nolting United States	15	244 0.8×	304 1.4×	265 1.4×	73 0.5×	143 1.4×	28	898
Michael Seiberling Switzerland	21	208 0.7×	221 1.0×	309 1.6×	121 0.8×	93 0.9×	45	1.6k
Ahmad Y. Abuhelwa Australia	17	137 0.5×	250 1.1×	240 1.3×	50 0.3×	92 0.9×	65	1.1k
Wing K. Cheung United States	18	174 0.6×	239 1.1×	250 1.3×	210 1.4×	194 1.9×	43	1.4k
Vikram Arya United States	18	180 0.6×	479 2.2×	177 0.9×	112 0.8×	93 0.9×	50	1.1k
Vijay Batra United States	17	118 0.4×	204 0.9×	216 1.1×	67 0.5×	222 2.2×	45	1.3k
Kohshi Nishiguchi Japan	19	136 0.5×	449 2.0×	318 1.7×	52 0.4×	123 1.2×	81	1.2k
Jakob Ribbing Sweden	10	116 0.4×	163 0.7×	126 0.7×	99 0.7×	174 1.7×	21	1.0k

Countries citing papers authored by Benjamin Weber

Since Specialization

Citations

This map shows the geographic impact of Benjamin Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Weber more than expected).

Fields of papers citing papers by Benjamin Weber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Weber. The network helps show where Benjamin Weber may publish in the future.

Co-authorship network of co-authors of Benjamin Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Weber. A scholar is included among the top collaborators of Benjamin Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Weber. Benjamin Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weber, Benjamin, et al.. (2024). How debunking biases in research and development decisions could lead to more equitable healthcare?. Clinical and Translational Science. 17(7). e13880–e13880. 1 indexed citations

Minichmayr, Iris K., Elodie L. Plan, Benjamin Weber, & Sebastian Ueckert. (2024). A Model-Based Evaluation of Noninvasive Biomarkers to Reflect Histological Nonalcoholic Fatty Liver Disease Scores. Pharmaceutical Research. 42(1). 123–135. 1 indexed citations

Kristoffersson, Anders, et al.. (2023). Bounded integer model‐based analysis of psoriasis area and severity index in patients with moderate‐to‐severe plaque psoriasis receiving BI 730357. CPT Pharmacometrics & Systems Pharmacology. 12(6). 758–769. 8 indexed citations

Schmid, Ulrike, Benjamin Weber, Céline Sarr, & Matthias Freiwald. (2021). Exposure–safety analyses of nintedanib in patients with chronic fibrosing interstitial lung disease. BMC Pulmonary Medicine. 21(1). 244–244. 12 indexed citations

Schmid, Ulrike, et al.. (2021). Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease. Respiratory Medicine. 180. 106369–106369. 10 indexed citations

Oesterle, Adam, Benjamin Weber, Roderick Tung, et al.. (2018). Preventing Postoperative Atrial Fibrillation After Noncardiac Surgery: A Meta-analysis. The American Journal of Medicine. 131(7). 795–804.e5. 22 indexed citations

Sharma, Ashish, Huib A.M. Kerstjens, René Aalbers, et al.. (2016). Pharmacokinetics of tiotropium administered by Respimat® in asthma patients: Analysis of pooled data from Phase II and III clinical trials. Pulmonary Pharmacology & Therapeutics. 42. 25–32. 11 indexed citations

Nguyen, Thi Huyen Tram, Samer Mouksassi, Nicholas H. G. Holford, et al.. (2016). Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics. CPT Pharmacometrics & Systems Pharmacology. 6(2). 87–109. 292 indexed citations breakdown →

Borghardt, Jens Markus, Benjamin Weber, Alexander Staab, & Charlotte Kloft. (2015). Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs. The AAPS Journal. 17(4). 853–870. 65 indexed citations

10.

Sharma, Ashish, Benjamin Weber, Martina Wein, Christoph Hallmann, & Bernd Meibohm. (2015). Essential criteria for pharmacokinetic studies supporting bioequivalence of inhaled tiotropium bromide products. Clinical Pharmacology in Drug Development. 5(1). 52–56. 2 indexed citations

11.

Weber, Benjamin, Sau L. Lee, Renishkumar Delvadia, et al.. (2014). Application of the Modified Chi-Square Ratio Statistic in a Stepwise Procedure for Cascade Impactor Equivalence Testing. The AAPS Journal. 17(2). 370–379. 8 indexed citations

12.

Weber, Benjamin, Sau L. Lee, Robert Lionberger, et al.. (2013). A Sensitivity Analysis of the Modified Chi-square Ratio Statistic for Equivalence Testing of Aerodynamic Particle Size Distribution. The AAPS Journal. 15(2). 465–476. 11 indexed citations

13.

Weber, Benjamin, Günther Hochhaus, Wallace P. Adams, et al.. (2012). A Stability Analysis of a Modified Version of the Chi-Square Ratio Statistic: Implications for Equivalence Testing of Aerodynamic Particle Size Distribution. The AAPS Journal. 15(1). 1–9. 15 indexed citations

14.

Weber, Benjamin & Günther Hochhaus. (2012). A Pharmacokinetic Simulation Tool for Inhaled Corticosteroids. The AAPS Journal. 15(1). 159–171. 50 indexed citations

15.

Weber, Benjamin, et al.. (2011). Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration. European Journal of Pharmaceutical Sciences. 45(1-2). 79–89. 12 indexed citations

16.

Jolivet, Renaud, et al.. (2009). BLOCKADE OF THE METABOTROPIC GLUTAMATE RECEPTOR MGLUR5 DOES NOT AFFECT NEUROVASCULAR COUPLING IN ADULT SPRAGUE-DAWLEY RATS. UCL Discovery (University College London). 1 indexed citations

17.

Wu, Kai, et al.. (2009). Budesonide and Ciclesonide: Effect of Tissue Binding on Pulmonary Receptor Binding. Drug Metabolism and Disposition. 37(7). 1421–1426. 12 indexed citations

18.

Stemmler, Hans‐Joachim, Peter A. Fasching, F. Melchert, et al.. (2007). Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer. Oncology. 73(5-6). 407–414. 20 indexed citations

19.

Barberi‐Heyob, Muriel, Jean‐Louis Merlin, & Benjamin Weber. (1992). Determination of 5-fluorouracil and its main metabolites in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 573(2). 247–252. 36 indexed citations

20.

Barberi‐Heyob, Muriel, Jean‐Louis Merlin, & Benjamin Weber. (1992). Analysis of 5-fluorouracil in plasma and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 581(2). 281–286. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact